In a 2020 nationwide population-based cohort study from France including 177,827 patients with IBD, ﻿Kirchgesner et al. analysed the effect of thiopurines and anti-TNF agents on the risk of acute arterial events (﻿IHD, CVA and PAD)144. Here, TNF is linked to inflammatory bowel disease.